Genome-wide identification of OTP gene as a novel methylation marker of breast cancer

Oncology Reports

Volumn 27, Issue 5, 2012, Pages 1681-1688

  Kim, Myung Soon ^a,c   Lee, Jinsun ^b   Oh, Taejeong ^a   Moon, Youngho ^a   Chang, Eilsung ^b   Seo, Kwang Sun ^b   Hoehn, Benjamin Douglas ^a   An, Sungwhan ^a   Lee, Jeung Hoon ^c  

^a Research and Development Center   (South Korea)

^b Chungnam National University College of Medicine   (South Korea)

^c Chungnam National University   (South Korea)

Author keywords

Breast cancer; Early detection; Methylation biomarker; OTP

Indexed keywords

GENOMIC DNA;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; CPG MICROARRAY; DISEASE MARKER; DNA ISOLATION; DNA METHYLATION; DNA MICROARRAY; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC CORRELATION; GENETIC SCREENING; GENOME ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LHX2 GENE; METHYLATED DNA ISOLATION ASSAY; OTP GENE; PRIMARY TUMOR; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; PYROSEQUENCING; TUMOR GENE; WT1 GENE;

ADULT; AGED; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA METHYLATION; FEMALE; GENE EXPRESSION PROFILING; GENOME-WIDE ASSOCIATION STUDY; HOMEODOMAIN PROTEINS; HUMANS; LIM-HOMEODOMAIN PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; WT1 PROTEINS;

EID: 84863247996     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1691     Document Type: Article

References (30)

1. Althuis MD, Dozier JM, Anderson WF, Devesa SS and Brinton LA: Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 34: 405-412, 2005. (Pubitemid 40645331)
2. Coughlin SS and Ekwueme DU: Breast cancer as a global health concern. Cancer Epidemiol 33: 315-318, 2009.
3. Esteller M: Cancer epigenetics: DNA methylation and chromatin alterations in human cancer. Adv Exp Med Biol 532: 39-49, 2003.
4. Watanabe Y and Maekawa M: Methylation of DNA in cancer. Adv Clin Chem 52: 145-67, 2010.
5. Laird PW: The power and the promise of DNA methylation markers. Nat Rev Cancer 3: 253-266, 2003.
6. Fackler MJ, McVeigh M, Evron E, Garrett E, Mehrotra J, Polyak K, Sukumar S and Argani P: DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma. Int J Cancer 107: 970-975, 2003. (Pubitemid 37429839)
7. Fujikane T, Nishikawa N, Toyota M, Suzuki H, Nojima M, Maruyama R, Ashida M, Ohe-Toyota M, Kai M, Nishidate T, Sasaki Y, Ohmura T, Hirata K and Tokino: Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer. Breast Cancer Res Treat 122: 699-710, 2010.
8. Hill VK, Ricketts C, Bieche I, Vacher S, Gentle D, Lewis C, Maher ER and Latif F: Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity. Cancer Res 71: 2988-2999, 2011.
9. Nass SJ, Herman JG, Gabrielson E, Iversen PW, Parl FF, Davidson NE and Graff JR: Aberrant methylation of the estrogen receptor and E-cadherin 5′-CpG islands increases with malignant progression in human breast cancer. Cancer Res 60: 4346-4348, 2000. (Pubitemid 32103608)
10. Tommasi S, Karm DL, Wu X, Yen Y and Pfeifer GP: Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer. Breast Cancer Res 11: R14, 2009.
11. Veeck J, Noetzel E, Bektas N, Jost E, Hartmann A, Knüchel R and Dahl E: Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer. Mol Cancer 7: 83, 2008.
12. Moon YH, Oh TJ, Kim NY, Kim MS and An SW: Methylated DNA isolation. Am Biotechnol Lab 27: 23-25, 2009.
13. Dworkin AM, Huang TH and Toland AE: Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment. Semin Cancer Biol 19: 165-171, 2009.
14. Widschwendter M and Jones PA: DNA methylation and breast carcinogenesis. Oncogene 21: 5462-5482, 2002. (Pubitemid 34983482)
15. Krassenstein R, Sauter E, Dulaimi E, Battagli C, Ehya H, Klein-Szanto A and Cairns P: Detection of breast cancer in nipple aspirate fluid by CpG island hypermethylation. Clin Cancer Res 10: 28-32, 2004. (Pubitemid 38114158)
16. Patel A, Groopman JD and Umar A: DNA methylation as a cancer-specific biomarker: from molecules to populations. Ann N Y Acad Sci 983: 286-297, 2003. (Pubitemid 36399341)
17. Fleischhacker M and Schmidt B: Circulating nucleic acids (CNAs) and cancer: a survey. Biochim Biophys Acta 1775: 181-232, 2007. (Pubitemid 44911084)
18. Schwarzenbach H, Stoehlmacher J, Pantel K and Goekkurt E: Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer. Ann N Y Acad Sci 1137: 190-96, 2008.
19. Stroun M, Lyautey J, Lederrey C, Olson-Sand A and Anker P: About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta 313: 139-142, 2001. (Pubitemid 33016703)
20. Dulaimi E, Hillinck J, Ibanez de Caceres I, Al-Saleem T and Cairns P: Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients. Clin Cancer Res 10: 6189-6193, 2004. (Pubitemid 39287525)
21. Hu XC, Wong IH and Chow LW: Tumor-derived aberrant methylation in plasma of invasive ductal breast cancer patients: clinical implications. Oncol Rep 10: 1811-1815, 2003.
22. Jing F, Zhang J, Tao J, Zhou Y, Jun L, Tang X, Wang Y and Hai H: Hypermethylation of tumor suppressor genes BRCA1, p16 and 14-3-3sigma in serum of sporadic breast cancer patients. Onkologie 30: 14-19, 2007. (Pubitemid 46175615)
23. Mirza S, Sharma G, Prasad CP, Parshad R, Srivastava A, Gupta SD and Ralhan R: Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients. Life Sci 81: 280-287, 2007. (Pubitemid 47030571)
24. Sharma G, Mirza S, Prasad CP, Srivastava A, Gupta SD and Ralhan R: Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients. Life Sci 80: 1873-1881, 2007. (Pubitemid 46562520)
25. Shukla S, Mirza S, Sharma G, Parshad R, Gupta SD and Ralhan R: Detection of RASSF1A and RARbeta hypermethylation in serum DNA from breast cancer patients. Epigenetics 1: 88-93, 2006.
26. Taback B, Giuliano AE, Lai R, Hansen N, Singer FR, Pantel K and Hoon DS: Epigenetic analysis of body fluids and tumor tissues: application of a comprehensive molecular assessment for early-stage breast cancer patients. Ann N Y Acad Sci 1075: 211-221, 2006. (Pubitemid 44532787)
27. Tan SH, Ida H, Lau QC, Goh BC, Chieng WS, Loh M and Ito Y: Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3. Oncol Rep 18: 1225-1230, 2007.
28. Acampora D, Postiglione MP, Avantaggiato V, Di Bonito M and Simeone A: The role of Otx and Otp genes in brain development.Int J Dev Biol 44: 669-677, 2000.
29. Ryu S, Mahler J, Acampora D, Holzschuh J, Erhardt S, Omodei D, Simeone A and Driever W: Orthopedia homeodomain protein is essential for diencephalic dopaminergic neuron development. Curr Biol 17: 873-880, 2007. (Pubitemid 46702667)
30. Wu X, Rauch TA, Zhong X, Bennett WP, Latif F, Krex D and Pfeifer GP: CpG island hypermethylation in human astrocytomas. Cancer Res 70: 2718-2727, 2010.